No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 14.2x · 10Y median 16.1x · 38th percentile · as of Sep 11, 2026
Annualized revenue (TTM) · by quarter, last 15
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-26T00:15:30.389Z. Latest historical point 2026-09-11. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Quote observation: 2026-09-26T00:15:30.389Z. Latest historical point 2026-09-11.
EV/EBITDA and cash-flow multiples are withheld until their applicability to this financial-services business is verified. The lenses that apply are shown above; see also P/B and ROE.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-26T00:15:30.389Z. Latest historical point 2026-09-11.
EBITDA and cash-flow yields are withheld until their applicability to this financial-services business is verified. Earnings yield is shown above; see also P/B and ROE.
The latest delayed quote for Brookfield Asset Management Ltd. (BAM) stock was $44.59 as of Sep 25, 2026, 4:00 PM EDT, up 0.02% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -13.4% · 3-year avg +13.6%/yr
Brookfield Asset Management operates as a prominent alternative asset manager and real estate investment trust (REIT), specializing in real estate, renewable energy, infrastructure, venture capital, and private equity assets. The firm provides a comprehensive range of public and private investment products and services to institutional and retail clients globally.
Asset Management · New York, NY
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 6, 2026
41 days away
EPS Estimate
0.47
Revenue Est.
$1.58B
Last Quarter Results
EPS
$0.44
vs Estimate
$0.44
Revenue
$1.73B
vs Estimate
$1.47B
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BAM | $71.20B | $44.59 | +0.02% | -13.39% | N/A | N/A | N/A |
| 2APO | $70.09B | $121.69 | +0.83% | -3.83% | +18.55% | +26.31% | vs BAM |
| 3TRV | $75.72B | $363.04 | +0.18% | +36.26% | +20.55% | +14.75% | vs BAM |
| 4SMH | $76.45B | $606.56 | +1.01% | +93.52% | +34.38% | +34.77% | vs BAM |
| 5NU | $65.82B | $13.59 | +0.26% | -6.41% | N/A | N/A | vs BAM |
| 6IWM | $77.56B | $281.97 | +0.11% | +22.97% | +6.68% | +10.40% | vs BAM |
TTM
13.18
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Consensus Rating
Based on 18 analysts
Average Price Target
$57.19
+28.3% upside
Low
$44.00
Current
$44.59
High
$70.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.44 | $0.47 | $0.52 | 9 |
| Quarter ending Dec 2026 | $0.45 | $0.50 | $0.54 | 8 |
| Quarter ending Mar 2027 | $0.51 | $0.52 | $0.53 | 3 |
| Quarter ending Jun 2027 | $0.53 | $0.54 | $0.56 | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.79 | $1.86 | $1.96 | 8 |
| FY 2027 | $2.08 | $2.20 | $2.32 | 9 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $1.55B | $1.58B | $1.60B | 5 |
| Quarter ending Dec 2026 | $1.63B | $1.67B | $1.69B | 5 |
| Quarter ending Mar 2027 | $1.68B | $1.72B | $1.75B | 4 |
| Quarter ending Jun 2027 | $1.75B | $1.78B | $1.82B | 4 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $6.11B | $6.18B | $6.25B | 6 |
| FY 2027 | $7.08B | $7.24B | $7.37B | 9 |
